BETHANEY JENKINS: Open Payments
NPI 1861674681 · CUSHING, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 86 payments from 28 companies in 2025. Trend: 2023 $1,046 · 2024 $1,085 · 2025 $1,464
Food & beverage: $1,465
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $227 |
| AstraZeneca Pharmaceuticals LP | 8 | $146 |
| GlaxoSmithKline, LLC. | 6 | $95 |
| Lundbeck LLC | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $65 |
| Novo Nordisk Inc | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Viatris Specialty LLC | 3 | $61 |
Products named: REXULTI, VRAYLAR, TRELEGY ELLIPTA, BREZTRI, CAPLYTA, AIRSUPRA, YUPELRI, PREVNAR 20.
Industry payments across OK — which companies pay providers there.
